Pharmaceutical Raw Materials and Their Stability: How to Ensure Consistent Quality During Production and Storage

Photo: Patrick Hendry / Unsplash

The production of pharmaceuticals requires not only precise technological processes but also raw materials with guaranteed stability. Degradation of active substances, changes in the physicochemical properties of excipients, or contamination can jeopardize not only the quality of the final product but also the health of patients. What factors influence the stability of pharmaceutical raw materials? And how to choose a supplier that ensures consistent quality from delivery to processing? These questions are sought after not only by manufacturers of generic drugs but also by innovative pharmaceutical companies that must comply with strict regulatory requirements.

Why the stability of pharmaceutical raw materials is crucial for the production process

The stability of pharmaceutical raw materials directly affects the safety, efficacy, and shelf life of the final medicinal product. Unstable raw materials can lead to the degradation of active substances, the formation of undesirable impurities, or the loss of therapeutic effect. This impacts not only product quality but also compliance with regulatory requirements, such as REACH and GHS regulations, which demand rigorous control of risks associated with chemical substances. Manufacturers must ensure that raw materials withstand influences such as temperature, humidity, light, or oxidation during both production and storage.

Consistency in the quality of raw materials is particularly crucial for sensitive substances, such as biologically active compounds, vitamins, or certain polymers. For example, vitamin C (ascorbic acid) is sensitive to oxidation and light, which can lead to its rapid degradation. Similarly, some surfactants or emulsifiers lose their properties when stored improperly. Selecting a supplier that guarantees the stability of raw materials and provides detailed documentation (e.g., certificates of analysis, stability studies) is therefore essential for minimizing risks in the manufacturing process.

How to Choose a Supplier of Pharmaceutical Raw Materials with a Focus on Stability

When selecting a supplier of pharmaceutical raw materials, several key factors influencing the stability and quality of the supplied substances must be considered. The first criterion is compliance with international standards and certifications, such as GMP (Good Manufacturing Practice) or ISO for the pharmaceutical industry. These standards ensure that raw materials are produced and stored under controlled conditions, minimizing the risk of contamination or degradation. It is also important to verify whether the supplier conducts regular stability tests of raw materials according to standard testing methods.

Another aspect is supplier transparency. A quality supplier provides detailed technical documentation, including raw material specifications, certificates of analysis (CoA), and stability data. This information should contain details on optimal storage conditions (temperature, humidity, protection from light) and the maximum shelf life. For sensitive substances, such as certain active pharmaceutical ingredients (API), it is advisable to request results from accelerated stability tests that simulate long-term storage under extreme conditions.

Photo: Ricardo Gomez Angel / Unsplash

Optimizing Storage Conditions to Maintain Raw Material Stability

Proper storage of pharmaceutical raw materials is just as important as their quality upon delivery. Each raw material requires specific conditions to prevent degradation or loss of efficacy. For example, hygroscopic substances, such as certain salts or sugars, must be stored in a dry environment with low humidity to avoid moisture absorption and subsequent degradation. Conversely, light-sensitive substances, such as some vitamins or dyes, should be kept in opaque containers or dark spaces.

Temperature is another critical factor. Most pharmaceutical raw materials should be stored at 15–25 °C, but some substances require refrigeration (2–8 °C) or even freezing (-20 °C). Exceeding the recommended temperatures can lead to chemical reactions, such as hydrolysis or oxidation, which reduce the stability of the raw materials. It is also important to ensure that storage areas are equipped with a temperature and humidity monitoring system to enable early detection of deviations from the specified conditions.

Practical Steps to Ensure Consistency of Raw Material Quality in Production

To ensure the consistency of pharmaceutical raw material quality, it is essential to implement a systematic approach that includes regular inspections and process validations. The first step is incoming raw material inspection, during which compliance with the specifications stated in the certificate of analysis is verified. This includes testing physicochemical properties, such as active ingredient content, pH, density, or solubility. For some raw materials, microbiological tests are also advisable, especially if they are intended for the production of sterile preparations.

Another important measure is the validation of manufacturing processes, which ensures that raw materials are processed under conditions that do not cause their degradation. This includes optimizing temperature regimes, mixing times, or pressure during tableting. Manufacturers should also regularly conduct stability studies of finished products to verify that raw materials retain their properties even after processing. Finally, thorough documentation of all processes and controls enables rapid detection and resolution of potential issues, thereby minimizing the risk of production disruptions.

Photo: American Public Power Association / Unsplash

Impact of raw material purity and specifications on their long-term stability

The stability of pharmaceutical raw materials begins with their chemical purity and precisely defined specifications. Even minor deviations in impurity content, moisture, or residual solvents can significantly affect a substance's reactivity and its resistance to degradation. For example, the presence of metal ions in some APIs (active pharmaceutical ingredients) can catalyze oxidative processes, leading to the formation of undesirable degradation products. Therefore, it is essential that suppliers provide raw materials with certified purity, ideally with analytical protocols verified according to standard pharmaceutical methods, such as HPLC or GC-MS.

An important parameter is also particle size and its distribution, especially for solid substances. Uneven particle size can cause issues with mixture homogeneity, which subsequently affects the stability of the final product. The supplier should guarantee consistent granulometry and provide detailed specifications, including tolerances for key parameters. In practice, this means that when selecting a raw material, it is necessary to verify not only the declared purity but also the actual analytical results from recent batches, which confirm the stability of these values over time.

The Role of Packaging Materials in Protecting the Stability of Pharmaceutical Raw Materials

The correct choice of packaging material is often an underestimated but critical factor in maintaining the stability of raw materials during storage and transport. The packaging material must be chemically inert to the contents to prevent substance migration or contamination. For example, some plastics may release plasticizers that react with sensitive APIs, while metal packaging can corrode and release ions. For sensitive substances, multilayer packaging with barrier properties is therefore often used, such as a combination of aluminum foil and polyethylene with low permeability to moisture and oxygen.

Protection from light is also important, particularly for photolabile substances. In such cases, opaque or dark-colored packaging, or packaging with a UV filter, is chosen. The supplier should be able to provide technical documentation for the packaging material, including data on permeability to moisture, oxygen, and light. For long-term storage, it is advisable to regularly check the integrity of the packaging and, in case of damage, immediately switch to an alternative solution to minimize the risk of raw material degradation.

Monitoring and Validation of Raw Material Stability Throughout Their Lifecycle

Ensuring the stability of pharmaceutical raw materials does not end with their acceptance into storage. It is necessary to establish a system for regular monitoring of key parameters that may indicate the onset of degradation. These parameters include, for example, moisture content, pH, color changes, or the formation of degradation products. Standard analytical methods such as spectroscopy, chromatography, or titration are used for this purpose, enabling the detection of even minimal deviations from specifications.

Stability validation should take place not only upon receipt of raw materials but also at regular intervals during storage, especially for substances with limited shelf life. Manufacturers should have clearly defined procedures for sampling and analysis, including criteria for withdrawing raw materials from further use. It is also important to document all results and compare them with historical data to identify trends and respond promptly to any deviations. Collaboration with the supplier on sharing raw material stability data can additionally provide valuable insights for optimizing storage conditions and extending the lifespan of raw materials.

Need Raw Materials with Verified Stability?

Every pharmaceutical raw material requires an individual approach – from proper storage conditions to validated analytical methods. GCG Group provides complete technical documentation with every delivery and advises on selecting raw materials that meet stability and safety requirements according to current pharmaceutical standards. Contact us – or browse our catalogue of over 1,300 products.